Company / Working Capital
ClearPoint Neuro, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$52.8M
FY2025
5-year range
$23.0M / $57.1M
FY2021-FY2025
Trend
+129.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital returned to growth in FY2025 after 3 years of decline, reaching $53M.
Based on SEC 10-K filings.
$53M in FY2025 with a 5-year CAGR of +18.9%.
Improved from $29M to $53M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- +6.0%
- 5-Year CAGR
- +18.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +18.9%, indicating consistent growth.
- In FY2025, working capital increased 129.6% year-over-year.
- Peak working capital was recorded in FY2021.
- Lowest working capital in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.71 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $52.8M | +129.6% |
| FY2024 | $23.0M | -19.9% |
| FY2023 | $28.7M | -35.3% |
| FY2022 | $44.4M | -22.3% |
| FY2021 | $57.1M | +156.7% |
| FY2020 | $22.3M | +239.8% |
| FY2019 | $6.6M | +36.8% |
| FY2018 | $4.8M | -42.7% |
| FY2017 | $8.3M | +172.2% |
| FY2016 | $3.1M | +249.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026